ʻO Vedolizumab Injection

Anter

• Hoʻohana ʻia ka injection Vedolizumab e hōʻoluʻolu i nā ʻōuli o kekahi mau maʻi autoimmune (nā kūlana e hoʻouka ai ka ʻōnaehana pale i nā ʻāpana olakino o ke kino a hōʻeha i ka ʻeha, ka pehu ʻana, a me nā hōʻino) o nā wahi gastrointestinal me:
• Ma mua o ka lawe ʻana iā vedolizumab,
• Hiki i nā Vedolizumab ke hana i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

Hoʻohana ʻia ka injection Vedolizumab e hōʻoluʻolu i nā ʻōuli o kekahi mau maʻi autoimmune (nā kūlana e hoʻouka ai ka ʻōnaehana pale i nā ʻāpana olakino o ke kino a hōʻeha i ka ʻeha, ka pehu ʻana, a me nā hōʻino) o nā wahi gastrointestinal me:

• ʻO ka maʻi o Crohn (kahi ʻano e hoʻouka ai ke kino i ka uhi o ka digestive tract, e hōʻeha ai i ka ʻeha, ka maʻi pākī, ka pohō kaumaha, a me ke kuni) ʻaʻole i hoʻomaikaʻi ʻia ke mālama ʻia me nā lāʻau ʻē aʻe.
• ulcerative colitis (ke kumu e kumu i ka pehu a me nā ʻeha i ka uhi ʻana o ka ʻōpū nui) ʻaʻole i hoʻomaikaʻi ʻia ke mālama ʻia me nā lāʻau ʻē aʻe.

ʻO ka injection Vedolizumab i loko o kahi papa o nā lāʻau i kapa ʻia nā antagonists receptor integrin. Hana ia ma ke kāpae ʻana i ka hana o kekahi mau hunaola i loko o ke kino e hoʻonā i ka wela.

ʻO ka injection Vedolizumab ke hele mai me he pauma e hoʻopili ʻia me ka wai sterile a ʻimi ʻino ʻia (i loko o kahi aa) ma mua o 30 mau minuke e ke kauka a kahu hānai paha. Hāʻawi pinepine ʻia ia i ke keʻena o ke kauka i hoʻokahi manawa i kēlā me kēia 2 a 8 mau pule, ʻoi aku ka pinepine i ka hoʻomaka o kāu lapaʻau a me ka liʻiliʻi o ka hoʻomau ʻana o kāu lapaʻau.

Hiki i ka injection Vedolizumab ke hana i nā hopena maʻi kūpilikia i ka wā o ka infusion a no kekahi mau hola ma hope. E nānā kahi kauka a kahu hānai paha iā ʻoe i kēia manawa e ʻike pono ʻaʻohe ou hopena koʻikoʻi i ka lāʻau. Hāʻawi ʻia ʻoe i nā lāʻau ʻē aʻe e mālama i nā hopena i ka inikū vedolizumab. E haʻi koke i kāu kauka a kahu hānai paha inā ʻike ʻoe i kekahi o nā ʻōuli ma hope a i ʻole a ma hope paha o kāu hoʻouluulu ʻana. ʻumeʻume; pehu o ka maka, maka, waha, ʻāʻī, elelo, a i ʻole mau lehelehe; pilikia i ka hanu ʻana a i ʻole ke ale ʻana; wheezing, pāheʻe; ʻūpā; wela wela; aiʻole kahi puʻuwai puʻuwai a wikiwiki paha.

Hiki i ka hoʻopili ʻana iā Vedolizumab ke kōkua i ke kaohi ʻana i kāu mau ʻōuli, akā ʻaʻole ia e hoʻōla i kou maʻi. E nānā pono kāu kauka iā ʻoe e ʻike i ka maikaʻi o ka hana o ka injection vedolizumab iā ʻoe. Inā ʻaʻole i hoʻomaikaʻi kāu kūlana ma hope o 14 mau pule, hiki i kāu kauka ke hoʻopau i ka mālama ʻana iā ʻoe me ka injection vedolizumab. He mea nui e haʻi i kāu kauka i kou ʻano i kou wā e mālama ai.

E hāʻawi aku kāu kauka a kauka paha iā ʻoe i ka palapala ʻike hoʻomanawanui a ka mea hana (Ke alakaʻi lāʻau) ke hoʻomaka ʻoe i ka lāʻau me ka inikū vedolizumab a i kēlā me kēia manawa ke loaʻa iā ʻoe ka lāʻau. E heluhelu pono i ka ʻike a nīnau i kāu kauka a kauka paha inā he nīnau kāu. Hiki iā ʻoe ke kipa aku i ka pūnaewele ʻo Food and Drug Administration (FDA) (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) a i ʻole pūnaewele o ka mea hana e kiʻi i ka Medication Guide.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka lawe ʻana iā vedolizumab,

• e haʻi i kāu kauka a me ka kauka inā he maʻi ʻoe i ka vedolizumab, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka inikū vedolizumab. E noi i kāu kauka lāʻau a nānā i ke alakaʻi lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. E hoʻomaopopo pono e ʻōlelo i kekahi o kēia mau mea: adalimumab (Humira), certolizumab (Cimzia), golimumab (Simponi), infliximab (Remicade), a i ʻole natalizumab (Tysabri). Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi aku i kāu kauka inā he mau pilikia kou ake, inā he maʻi pākī ʻoe a i ʻole i launa pū me kekahi me ka maʻi puʻupuʻu, a i ʻole inā he manaʻo paha kāu i loaʻa i kahi maʻi, a inā he maʻi ʻoe i hele mai a i ʻole nā ​​maʻi i hoʻomau mau ʻia hele ole.
• E haʻi i kāu kauka inā hāpai ʻoe, e hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka lawe ʻana iā vedolizumab, kāhea i kāu kauka.
• e nīnau i kāu kauka inā pono ʻoe e loaʻa i nā lāʻau āpau ma mua o kou hoʻomaka ʻana i kāu lāʻau me ka inikū vedolizumab. Inā hiki, pono e hāpai i nā lāʻau āpau āpau ma mua o ka hoʻomaka ʻana o ka lāʻau. ʻAʻohe o nā lāʻau lapaʻau i ka wā o kāu mālama ʻana me ke kamaʻilio ʻole ʻana me kāu kauka.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inā haʻalele ʻoe i kahi manawa e loaʻa ai kahi infus vedolizumab, kāhea koke i kāu kauka.

Hiki i nā Vedolizumab ke hana i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• ʻeha poʻo
• nausea
• ʻeha hui a kua ʻeha paha
• ʻeha ma kou mau lima a me kou mau wāwae

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

• fiva, uha, ihu ihu, ʻeha ka ʻāʻī, ʻalalā, ʻeha a me nā hōʻailona ʻē aʻe o ka maʻi
• ʻulaʻula a ʻeha ʻeha a ʻeha paha ma kou kino
• ʻeha i ka wā o ka urination
• huikau a me nā pilikia hoʻomanaʻo paha
• lilo o ke kaulike
• nā hoʻololi i ka hele wāwae ʻana a i ʻole ka walaʻau ʻana
• hoʻemi i ka ikaika a i ʻole nāwaliwali ma kekahi ʻaoʻao o kou kino
• ʻike hihi a pohihihi paha o ka hihiʻo
• luhi loa
• nalo ʻai ʻole
• ʻeha ma ka ʻaoʻao ʻākau o luna o ka ʻōpū
• ʻāpā ʻaʻano ʻole a hoʻokahe koko paha
• mimi ʻeleʻele
• melemele o ka ʻili a me nā maka

Hiki iā Vedolizumab ke hana i nā hopena ʻē aʻe. Kāhea i kāu kauka inā he pilikia ʻokoʻa kāu i ka lawe ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

Mālama i nā manawa āpau me kāu kauka.

E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i vedolizumab.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Entyvio^®